191 related articles for article (PubMed ID: 36738297)
1. Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry.
Reddi RN; Rogel A; Gabizon R; Rawale DG; Harish B; Marom S; Tivon B; Arbel YS; Gurwicz N; Oren R; David K; Liu J; Duberstein S; Itkin M; Malitsky S; Barr H; Katz BZ; Herishanu Y; Shachar I; Shulman Z; London N
J Am Chem Soc; 2023 Feb; 145(6):3346-3360. PubMed ID: 36738297
[TBL] [Abstract][Full Text] [Related]
2. Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry.
Reddi RN; Resnick E; Rogel A; Rao BV; Gabizon R; Goldenberg K; Gurwicz N; Zaidman D; Plotnikov A; Barr H; Shulman Z; London N
J Am Chem Soc; 2021 Apr; 143(13):4979-4992. PubMed ID: 33761747
[TBL] [Abstract][Full Text] [Related]
3. Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry.
Reddi RN; Rogel A; Resnick E; Gabizon R; Prasad PK; Gurwicz N; Barr H; Shulman Z; London N
J Am Chem Soc; 2021 Dec; 143(48):20095-20108. PubMed ID: 34817989
[TBL] [Abstract][Full Text] [Related]
4. A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk
Gui F; Jiang J; He Z; Li L; Li Y; Deng Z; Lu Y; Wu X; Chen G; Su J; Song S; Zhang YM; Yun CH; Huang X; Weisberg E; Zhang J; Deng X
Br J Pharmacol; 2019 Dec; 176(23):4491-4509. PubMed ID: 31364164
[TBL] [Abstract][Full Text] [Related]
5. Bicyclobutane Carboxylic Amide as a Cysteine-Directed Strained Electrophile for Selective Targeting of Proteins.
Tokunaga K; Sato M; Kuwata K; Miura C; Fuchida H; Matsunaga N; Koyanagi S; Ohdo S; Shindo N; Ojida A
J Am Chem Soc; 2020 Oct; 142(43):18522-18531. PubMed ID: 33047956
[TBL] [Abstract][Full Text] [Related]
6. Improved Electrophile Design for Exquisite Covalent Molecule Selectivity.
Montaño JL; Wang BJ; Volk RF; Warrington SE; Garda VG; Hofmann KL; Chen LC; Zaro BW
ACS Chem Biol; 2022 Jun; 17(6):1440-1449. PubMed ID: 35587148
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit.
Qiu H; Liu-Bujalski L; Caldwell RD; Follis AV; Gardberg A; Goutopoulos A; Grenningloh R; Head J; Johnson T; Jones R; Mochalkin I; Morandi F; Neagu C; Sherer B
Bioorg Med Chem Lett; 2018 Sep; 28(17):2939-2944. PubMed ID: 30122225
[TBL] [Abstract][Full Text] [Related]
8. Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.
Hermann MR; Pautsch A; Grundl MA; Weber A; Tautermann CS
J Comput Aided Mol Des; 2021 Apr; 35(4):531-539. PubMed ID: 33015740
[TBL] [Abstract][Full Text] [Related]
9. Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib.
Hopper M; Gururaja T; Kinoshita T; Dean JP; Hill RJ; Mongan A
J Pharmacol Exp Ther; 2020 Mar; 372(3):331-338. PubMed ID: 31871305
[TBL] [Abstract][Full Text] [Related]
10. Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.
Lee-Vergés E; Hanna BS; Yazdanparast H; Rodríguez V; Rodríguez ML; Giró A; Vidal-Crespo A; Rosich L; Amador V; Aymerich M; Villamor N; Delgado J; Lichter P; Pérez-Galán P; López-Guerra M; Campo E; Seiffert M; Colomer D
Int J Cancer; 2019 Jun; 144(11):2762-2773. PubMed ID: 30468254
[TBL] [Abstract][Full Text] [Related]
11. Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine.
Tang KC; Cao J; Boatner LM; Li L; Farhi J; Houk KN; Spangle J; Backus KM; Raj M
Angew Chem Int Ed Engl; 2022 Jan; 61(5):e202112107. PubMed ID: 34762358
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk.
Caldwell R; Liu-Bujalski L; Qiu H; Mochalkin I; Jones R; Neagu C; Goutopoulos A; Grenningloh R; Johnson T; Sherer B; Gardberg A; Follis AV; Morandi F; Head J
Bioorg Med Chem Lett; 2018 Nov; 28(21):3419-3424. PubMed ID: 30290988
[TBL] [Abstract][Full Text] [Related]
13. Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins.
Yang Y; Shu YZ; Humphreys WG
Chem Res Toxicol; 2016 Jan; 29(1):109-16. PubMed ID: 26675335
[TBL] [Abstract][Full Text] [Related]
14. Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.
Barf T; Covey T; Izumi R; van de Kar B; Gulrajani M; van Lith B; van Hoek M; de Zwart E; Mittag D; Demont D; Verkaik S; Krantz F; Pearson PG; Ulrich R; Kaptein A
J Pharmacol Exp Ther; 2017 Nov; 363(2):240-252. PubMed ID: 28882879
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation.
Zhang T; Hatcher JM; Teng M; Gray NS; Kostic M
Cell Chem Biol; 2019 Nov; 26(11):1486-1500. PubMed ID: 31631011
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of BTK active site inhibitors on the conformational state of full-length BTK.
Joseph RE; Amatya N; Fulton DB; Engen JR; Wales TE; Andreotti A
Elife; 2020 Nov; 9():. PubMed ID: 33226337
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors.
Ábrányi-Balogh P; Keeley A; Ferenczy GG; Petri L; Imre T; Grabrijan K; Hrast M; Knez D; Ilaš J; Gobec S; Keserű GM
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558935
[TBL] [Abstract][Full Text] [Related]
18. HZ-A-005, a potent, selective, and covalent Bruton's tyrosine kinase inhibitor in preclinical development.
Huang W; Wang S; Zhang Z; Zhang C; Zeng S; Liang M; Shen Z; Liu X
Bioorg Chem; 2020 Dec; 105():104377. PubMed ID: 33091668
[TBL] [Abstract][Full Text] [Related]
19. Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance.
St-Pierre F; Ma S
Blood Lymphat Cancer; 2022; 12():81-98. PubMed ID: 35911566
[TBL] [Abstract][Full Text] [Related]
20. Peptide-Based Covalent Inhibitors Bearing Mild Electrophiles to Target a Conserved His Residue of the Bacterial Sliding Clamp.
Compain G; Monsarrat C; Blagojevic J; Brillet K; Dumas P; Hammann P; Kuhn L; Martiel I; Engilberge S; Oliéric V; Wolff P; Burnouf DY; Wagner J; Guichard G
JACS Au; 2024 Feb; 4(2):432-440. PubMed ID: 38425897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
